SinglePoint Inc. subsidiary BPA Solutions, released footage from a recent demonstration of their newest product offering, the LifeShield+ ballistic door panel. The demonstration highlighted the capabilities of the LifeShield+ and showed how it can withstand various firearms.

Sunshine Biopharma Inc today announced its board of directors has authorized a share repurchase program to acquire up to $2 million of the Company’s common stock.

Mawson’s installed operational capacity as of December 31, 2022 was approximately 2.9 Exahash across Bitcoin Self-Mining and Hosting Co-locations Approximately $4 million in revenue generated from Mawson’s Energy Market Program in December, $13.9 million generated in 2022.

SinglePoint, Inc. subsidiary, BPA Solutions, recognizes the substantial market opportunity for states to continue funding and prioritizing clean indoor air as the Biden administration extends the COVID-19 Public Health Emergency due to omicron sub-variants.

SinglePoint Inc.'s subsidiary, BPA Solutions, recognizes the potential for schools to promote healthier learning environments through better indoor air quality as students and staff return for the start of the new semester.

Sharps Technology, Inc. announces the advancement of the Company's specialized prefillible syringe ("PFS") system product line, which will be manufactured in collaboration with Nephron Pharmaceuticals at the Inject EZ facility in West Columbia, South Carolina.

SinglePoint is proud to announce that its subsidiary, Boston Solar, is near completion of the commercial rooftop solar installation of the MGM Music Hall at Fenway.